CDKN2A and neoplasm: Consistent with the TCGA data, western blot analysis demonstrated markedly higher CDKN2A protein levels in tumour tissues compared to their normal counterparts (Figure 4C), confirming the clinical relevance of CDKN2A overexpression in CRC.